Shared more. Cited more. Safe forever.
    • advanced search
    • submit works
    • about
    • help
    • contact us
    • login
    View Item 
    •   MOspace Home
    • University of Missouri-Columbia
    • Missouri Technology Expo (MU)
    • Missouri Technology Expo 2010 (MU)
    • Abstracts (Missouri Technology Expo 2010)
    • View Item
    •   MOspace Home
    • University of Missouri-Columbia
    • Missouri Technology Expo (MU)
    • Missouri Technology Expo 2010 (MU)
    • Abstracts (Missouri Technology Expo 2010)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    advanced searchsubmit worksabouthelpcontact us

    Browse

    All of MOspaceCommunities & CollectionsDate IssuedAuthor/ContributorTitleSubjectIdentifierThesis DepartmentThesis AdvisorThesis SemesterThis CollectionDate IssuedAuthor/ContributorTitleSubjectIdentifierThesis DepartmentThesis AdvisorThesis Semester

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular AuthorsStatistics by Referrer

    Relative study between anti-EGFR and GE-11 peptide conjugated gold nanoparticles for in vivo targeting in pancreatic cancer [abstract]

    Chanda, Nripen
    Zambre, Ajit
    Shukla, Ravi
    Mukharjee, Priyabrata
    Mukhopadhyay, Debabrata
    Boote, Evan
    Kannan, Raghuraman
    Katti, Kattesh V.
    View/Open
    [PDF] RelativeStudyAntiEFGR[abstract].pdf (51.59Kb)
    Date
    2010-10
    Format
    Abstract
    Metadata
    [+] Show full item record
    Abstract
    Pancreatic cancer is the fourth leading cause of cancer related deaths in the United States due to its severe aggressiveness and lethal malignancy. Epidermal Growth Factor Receptor (EGFR) is over expressed in more than 95% of human pancreatic cancer patients. A number of peptides and monoclonal antibodies have been developed to target the EGFR in pancreatic cancer. Our research has focused on developing EGFR targeting biomolecule conjugated gold nanoparticles for the diagnosis and staging of various cancers. In this study, we have synthesized a series of Antibody EGFR and EGFR-peptide (GE-11) conjugated AuNPs. We investigated the in vivo EGFR targeting characteristics of these conjugates in pancreatic tumor bearing SCID mice models. Our investigation has provided evidence that the peptide conjugated AuNPs have high in vivo mobility and targets pancreatic tumor effectively. We have also established that the EGFR-peptide-AuNP conjugates serve as better X-ray contrast agents for early detection of pancreatic cancer in mice models. The details of this comparative study will be presented in this poster.
    URI
    http://hdl.handle.net/10355/9779
    Part of
    Abstracts (Missouri Technology Expo 2010)
    Collections
    • Abstracts (Missouri Technology Expo 2010)

    Send Feedback
    hosted by University of Missouri Library Systems
     

     


    Send Feedback
    hosted by University of Missouri Library Systems